[Medical treatment of ozena].
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D012110:Reserpine / Q000627:therapeutic use*; D012222:Rhinitis, Atrophic / Q000188:drug therapy* / Q000209:etiology; D012459:Salicylates / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D002800:Cholinesterase Inhibitors; D012459:Salicylates; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents; D004088:Dihydroergotoxine; D006632:Histamine; D012110:Reserpine
Contribuţii la tratamentul medicamentos al ozenei.